EyePoint Pharmaceuticals Inc. buy Robert W. Baird
Start price
08.05.24
/
50%
€10.75
Target price
08.05.25
€35.34
Performance (%)
-27.07%
Price
05.07.24
€7.84
Summary
This prediction is currently active. The prediction for EyePoint Pharmaceuticals Inc. disappoints with a performance of -27.07%. This prediction currently runs until 08.05.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
EyePoint Pharmaceuticals Inc. | -3.474% | -3.474% |
iShares Core DAX® | 1.395% | -0.696% |
iShares Nasdaq 100 | 2.287% | 7.501% |
iShares Nikkei 225® | 1.617% | 2.769% |
iShares S&P 500 | 0.659% | 4.280% |
Comments by Robert_W__Baird for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Robert W. Baird from $46.00 to $38.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Robert_W__Baird for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.40
20.04.23
20.04.23
-
20.04.24
20.04.24
205.00%
21.04.24
21.04.24